Post-earnings recap
Reported
Tue, Feb 25, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
United Therapeutics reported a strong EPS performance, exceeding expectations significantly. However, the stock fell by 3.86% on the day, likely due to the lack of revenue figures and forward guidance. Investors may be cautious as they await more detailed financial insights in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.88 | N/A | +70.92% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS results despite not providing revenue figures.
They highlighted ongoing efforts to enhance product offerings and market presence.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—